SMS Pharmaceuticals Profit & Loss Annual

BSE: 532815 | NSE: SMSPHARMA | ISIN: INE812G01025 | Sector: Biotechnology & Drugs

248.25 +7.00 (2.90%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	709.26	522.05	519.87	563.18
Total Revenue	709.26	522.05	519.87	563.18
Costof Revenue Total	497.71	379.78	315.99	370.05
Gross Profit	211.56	142.27	203.88	193.12
Selling/ General/ Admin Expenses Total	64.15	87.69	89.55	72.00
Depreciation/ Amortization	31.52	32.13	32.15	22.28
Other Operating Expenses Total	30.79	-	-	-
Total Operating Expense	624.16	499.60	437.69	464.34
Operating Income	85.10	22.45	82.18	98.84
Interest Inc( Exp) Net- Non- Op Total	-234.57	-162.82	-147.29	-93.43
Other Net	4.46	-0.75	1.05	1.63
Net Income Before Taxes	66.11	5.35	68.50	91.12
Provisionfor Income Taxes	16.91	1.47	0.62	30.16
Net Income After Taxes	49.20	3.88	67.88	60.96
Equity In Affiliates	6.26	-109.43	-56.61	15.62
Net Income Before Extra Items	49.83	-7.06	62.22	62.53
Net Income	49.83	-7.06	62.22	62.53
Income Availableto Com Excl Extra Ord	49.83	-7.06	62.22	62.53
Income Availableto Com Incl Extra Ord	49.83	-7.06	62.22	62.53
Diluted Net Income	49.83	-7.06	62.22	62.53
Diluted Weighted Average Shares	8.46	8.47	8.47	8.47
Diluted EPS Excluding Extra Ord Items	5.89	-0.83	7.35	7.39
DPS- Common Stock Primary Issue	0.40	0.30	0.30	0.30
Diluted Normalized EPS	5.89	-0.83	7.35	7.39
Gain( Loss)on Saleof Assets	-	-0.72	-0.04	-0.08